29 Dec 2021 Bio-Thera Solutions Announces Initiation of Phase I Clinical Trials for BAT6005, a Monoclonal Antibody Targeting TIGIT Press Releases
29 Dec 2021 EDITOR´S PICK The Effects of Social Media on Public Attention and Attitudes Towards COVID-19 Vaccines in the UK Press Releases Researchers at Oxford University’s Department of Psychiatry and Sweden’s Karolinska Institute have analysed social media to investigate associations between…
29 Dec 2021 Valemetostat New Drug Application Submitted in Japan for Treatment of Patients with Adult T-Cell Leukemia/Lymphoma Press Releases
29 Dec 2021 LEO Pharma Announces FDA Approval of Adbry™ (tralokinumab) as the First and Only Treatment Specifically Targeting IL-13 for Adults With Moderate-to-Severe Atopic Dermatitis Press Releases
29 Dec 2021 RIBOMIC Announces Preliminary Topline Data From Phase 2 Trials of RBM-007 for Wet Age-Related Macular Degeneration Press Releases
29 Dec 2021 Therapeutic Solutions International Awarded Landmark Patent for Cancer and COVID-19 Treatment Press Releases OCEANSIDE, Calif.–(
27 Dec 2021 Cyrus Biotechnology’s COVID therapeutic lead, ACE2.v2.4, strongly binds and neutralizes SARS-CoV-2 omicron variant potentially providing long term protection Press Releases
27 Dec 2021 KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Approved in Japan for Patients With Unresectable, Advanced or Recurrent Endometrial Carcinoma That Progressed After Cancer Chemotherapy Press Releases
